Post by Scripps Research

At some point in the aging process, the body loses its ability to regenerate cells, organs and tissues. Scripps Research President and CEO Peter Schultz and Associate Professor Michael Bollong want to understand when exactly that is. Bollong first dove into the body’s regenerative pathways—the inherent mechanisms that dictate tissue growth and organ repair—during his PhD work in the Schultz lab. Today, they work closely with the Calibr-Skaggs Institute for Innovative Medicines' team to identify medicines that can precisely target these pathways. Much of this research builds on Schultz’s pioneering work in the field, which was originally based on the hypothesis that small molecules could control cell fate throughout the body. More: https://ow.ly/wra850Z2tQ3